“Alzheimer’s disease is preventable. We know what starts the disease and we have the tools to fix it.”

- Paul Aisen, MD, Epstein Alzheimer's Disease Director's Chair; Director, USC Alzheimer's Therapeutic Research Institute

There are currently 6 million people in the U.S. living with Alzheimer’s disease. In just 25 years, that number is set to balloon to 13 million. From the immense toll shouldered by patients, families, and caregivers to the unsustainable cost of care, this is a crisis that threatens the fabric of our society and the stability of our health care system.

What if we could prevent Alzheimer’s altogether, and stop it from ever taking hold? What would it mean—for our families and the future of health care—if those most at risk never developed the disease at all? What if we could do this in the next ten years?

USC is where the world turns for leadership in Alzheimer’s disease—and where philanthropy can make a decisiveimpact.

Dr. Paul Aisen and the USC Alzheimer’s Therapeutic Research Institute (ATRI) have played a role in the most consequential discoveries and innovations in Alzheimer’s disease. This is why those who are most invested in achieving results choose to place their support with USC—from leading philanthropic institutions such as the Alzheimer’sAssociation to our top-ranked funding support from the NIH to philanthropists like you.

Thank you for your support of ATRI. Together, we can make Alzheimer’s disease prevention a reality in the next ten years.